Related Experiment Video
Updated: Aug 9, 2026
12:58
Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
Published on: May 10, 2017
Summary
A new treatment combining chemotherapy and radiotherapy improved outcomes for childhood non-Hodgkin
Area of Science:
- Pediatric Oncology
- Hematology
- Clinical Research
Background:
- Childhood non-Hodgkin's lymphoma historically had a poor prognosis.
- Advancements in treatment protocols are crucial for improving survival rates.
Purpose of the Study:
- To evaluate the efficacy of a novel combination chemotherapy and radiotherapy program for childhood non-Hodgkin's lymphoma.
- To assess the impact of protocol modifications, including high-dose methotrexate, on treatment outcomes.
Main Methods:
- A cohort of 31 untreated children with biopsy-proven non-Hodgkin's lymphoma were enrolled.
- Treatment involved vincristine, steroid induction, intrathecal methotrexate, and a maintenance phase with 6-mercaptopurine and methotrexate.
- High-dose methotrexate was added to the protocol for Stage IV disease midway through the study.
Main Results:
- Overall, 63% (19/30) of patients remain disease-free for 15+ to 63+ months.
- 12 of 13 patients with Stage I and II disease achieved disease-free status.
- The addition of high-dose methotrexate improved outcomes in Stage IV disease (3/5 vs. 1/7 disease-free).
Conclusions:
- The implemented combination chemotherapy and radiotherapy program significantly improved the prognosis for childhood non-Hodgkin's lymphoma.
- Protocol modifications, particularly the inclusion of high-dose methotrexate, demonstrated a positive impact on survival, especially in advanced stages.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:16Primary Lymphoid Organs
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
01:15Secondary Lymphoid Organs
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...